Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

The problem of polypharmacy in psychiatry

Allen Frances, MD
Meds
July 14, 2016
Share
Tweet
Share

Polypharmacy was once the exception in psychiatry; now it seems to have become the rule. Patients frequently are taking 3, 4, even 5 psych meds at one time. And often it’s primary care doctors, not psychiatrists, who are doing the prescribing — usually without adequate training in psychiatry.

Some polypharmacy is rational — e.g., a patient with bipolar disorder who receives the combination of antidepressant and mood stabilizer.

But most polypharmacy is irrational — the result of carelessly adding meds without ever subtracting them; of treating each individual symptom separately; of chasing side effects; of too many docs providing uncoordinated care; and of patients demanding more meds than are good for them.

Polypharmacy has never been, and will never be, systematically studied in controlled clinical trials. It is hard enough doing simple studies comparing drug A vs. drug B vs. placebo. It is impossibly impractical to do studies comparing multiple drug regimen, because these would require too many cells and too big a sample size to test all the possible permutations. The result: Polypharmacy is rarely ever evidence-based, almost always a shot in the dark.

I have asked Dr. Luis Bastida Ribas, the director of a psychiatric clinic in Spain, to provide a clinician’s perspective on polypharmacy.

Dr. Bastida Ribas writes:

The patients referred to our clinic often arrive already taking many medications. Getting to know patients well enough for good diagnosis and treatment requires a lot of time that doctors don’t have. The easiest thing for a doctor to do to get the patient out of the office is give a pill. Or maybe 2 or 3 different kinds of pill. And often patients want unrealistically fast solutions to problems. If the problem doesn’t get solved quickly or completely, the doctor and patient may resort to polypharmacy.

More problems mean more pills, but more pills worsen the side effects. Too often, side effects are misidentified as new disease symptoms that require even more meds. Polypharmacy occurs nearly everywhere in the world as more and more people are taking more and more meds.

Polypharmacy causes at least six different types of problem:

1. Polypharmacy makes it impossible to know which med(s) work and which don’t and which meds are causing which side effects.

2. Polypharmacy usually results in more harm from accumulated side effects than benefit in improvement of symptoms.

3. Polypharmacy can lead to overdose and even death, accidentally or in suicide attempts, especially if the prescribed drugs are combined with alcohol or with other unprescribed drugs.

4. Polypharmacy triggers abstinence when patients quit meds abruptly (and they will if you give them too much). Relapse risk is higher, and new stressful withdrawal symptoms will appear that may be confused with recurrence of the original problem.

5. Polypharmacy requires complex and confusing pill taking regimen that patients usually don’t get right; they often take too much or too little of the medications prescribed or take them erratically.

ADVERTISEMENT

6. Polypharmacy is often extremely expensive; an economic burden on the patient and/or the treatment system that deprives resources better spent on other services.

We should be spending less of our resources on medications that may be harmful, more to support time for getting to know the patient better and to provide better services and housing.

Deprescribing must be done very slowly, one drug at a time, and under close medical supervision alert to signs of withdrawal or relapse. Patients often feel much better as side effects are reduced or disappear altogether.

Thanks so much Dr. Bastida Ribas. Polypharmacy is particularly common and particularly problematic in the elderly. The older the patient, the more likely that many different drug prescriptions have accumulated over time. Doctors are much better at starting meds than stopping them.

Polypharmacy is also often a particular disaster in the elderly because they are less good at clearing meds and metabolites and are thus prone to cumulative side effects. These are often then misdiagnosed as new symptoms and mistreated by adding even more toxic medicine. Any psych symptom in an elderly person should always first be considered a drug side effect.

If you are on multiple meds, don’t stop or reduce any of them because of what has been said above. Deprescribing requires more skill than prescribing and stopping meds is lots harder than starting them. Changes must always be very gradual and in close collaboration with the doctor.

Allen Frances is a psychiatrist and professor emeritus, Duke University.  He blogs at the Huffington Post.

Image credit: Shutterstock.com

Prev

Always check the back seat before you leave the car

July 14, 2016 Kevin 7
…
Next

There are limits to what a careful physician can do

July 15, 2016 Kevin 9
…

Tagged as: Medications, Psychiatry

Post navigation

< Previous Post
Always check the back seat before you leave the car
Next Post >
There are limits to what a careful physician can do

ADVERTISEMENT

More by Allen Frances, MD

  • #MeToo shows why women must learn sexual self-defense

    Allen Frances, MD
  • Pay primary care doctors what they’re worth

    Allen Frances, MD
  • Have we gone too far down the road of privatization?

    Allen Frances, MD

Related Posts

  • Who’s responsible for polypharmacy in the elderly?

    Michael Kirsch, MD
  • Scenes from a medical student’s rotation in psychiatry

    Natalia Birgisson
  • Why a prison psychiatry rotation should be mandatory for all medical students

    Tiana Walker
  • The life cycle of medication consumption

    Fery Pashang, PharmD
  • The abundant and colorful world of pharmaceuticals

    Fery Pashang, PharmD
  • Colorful pills don’t paint my world

    Fery Pashang, PharmD

More in Meds

  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

    Adwait Chafale
  • A psychiatrist’s 20-year journey with ketamine

    Muhamad Aly Rifai, MD
  • How drug companies profit by inventing diseases

    Martha Rosenberg
  • Most Popular

  • Past Week

    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
    • Why kratom addiction is emerging as a hidden public health crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Expanding the Parkinson’s universe of care for patients, caregivers, clinicians, and communities

      Ray Dorsey, MD and Michael Okun, MD | Conditions
    • What is financial therapy for physicians?

      David B. Mandell, JD, MBA | Finance
    • Lessons on compassion and autonomy from One Flew Over the Cuckoo’s Nest

      Thi My Nguyet Nguyen, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
  • Recent Posts

    • Expanding the Parkinson’s universe of care for patients, caregivers, clinicians, and communities

      Ray Dorsey, MD and Michael Okun, MD | Conditions
    • How to choose the right doctor for you

      Edward G. Rogoff | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI in your health care: a double-edged digital disruptor

      Alan P. Feren, MD | Tech
    • The crisis of antisemitism in our hospitals

      Carrie Friedman, NP | Policy
    • Why the future of AI in medicine is patient-facing

      Colin Son, MD | Tech

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
    • Why kratom addiction is emerging as a hidden public health crisis [PODCAST]

      The Podcast by KevinMD | Podcast
    • Expanding the Parkinson’s universe of care for patients, caregivers, clinicians, and communities

      Ray Dorsey, MD and Michael Okun, MD | Conditions
    • What is financial therapy for physicians?

      David B. Mandell, JD, MBA | Finance
    • Lessons on compassion and autonomy from One Flew Over the Cuckoo’s Nest

      Thi My Nguyet Nguyen, MD | Physician
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
  • Recent Posts

    • Expanding the Parkinson’s universe of care for patients, caregivers, clinicians, and communities

      Ray Dorsey, MD and Michael Okun, MD | Conditions
    • How to choose the right doctor for you

      Edward G. Rogoff | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI in your health care: a double-edged digital disruptor

      Alan P. Feren, MD | Tech
    • The crisis of antisemitism in our hospitals

      Carrie Friedman, NP | Policy
    • Why the future of AI in medicine is patient-facing

      Colin Son, MD | Tech

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

The problem of polypharmacy in psychiatry
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...